A methionine aminopeptidase-2 (MetAP2) inhibitor may exhibit anti-proliferative and anti-invasive abilities in CCA cell lines through the c-Myc, MMP2, and MMP9 pathways [51]. This evidence concerns the gene METAP2 and cholangiocarcinoma.